Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Orchid Pharma Ltd

Pharmaceuticals & Biotechnology | Small Cap

Orchid Pharma Ltd Health Insights
Health Score : 4.85Health Score : 4.85

Orchid Pharma Ltd demonstrates a mixed financial performance. The company shows some strength in solvency, driven by a solid equity position. Growth is fueled by operating profit and asset increases. Profitability is supported by a good return on capital employed and return on assets. However, liquidity is a significant concern due to poor current, quick, and cash ratios. Efficiency is also a trouble area, as key turnover ratios are low. Financial ratios are hindered by low earnings per share and book value. While coverage is reasonable, it is mainly due to interest coverage rather than equity dividend coverage. The company needs to address its liquidity and efficiency challenges to ensure long-term sustainability and growth.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Orchid Pharma Ltd Health Insights
Health Score : 4.85Health Score : 4.85

Orchid Pharma Ltd demonstrates a mixed financial performance. The company shows some strength in solvency, driven by a solid equity position. Growth is fueled by operating profit and asset increases. Profitability is supported by a good return on capital employed and return on assets. However, liquidity is a significant concern due to poor current, quick, and cash ratios. Efficiency is also a trouble area, as key turnover ratios are low. Financial ratios are hindered by low earnings per share and book value. While coverage is reasonable, it is mainly due to interest coverage rather than equity dividend coverage. The company needs to address its liquidity and efficiency challenges to ensure long-term sustainability and growth.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

109.88

Highly Overvalued

Industry Median

28.62

Highly Overvalued
Highly Overvalued

Small Cap Median

27.17

Highly Overvalued

P/E RATIO

241.74

P/B RATIO

3.85

Overvalued

Industry Median

3.17

Overvalued
Overvalued

Small Cap Median

2.62

Overvalued

P/S RATIO

5.70

Highly Overvalued

Industry Median

3.42

Highly Overvalued
Highly Overvalued

Small Cap Median

2.55

Highly Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

70.60

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹979.05 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.00

The company shows good operating profit and asset growth. However, revenue and net income growth are not doing good. The weighted average calculation shows that while some areas are growing, others are lagging. The company needs to focus on driving revenue and net income growth to achieve more balanced and sustainable growth.

PoorRevenue Growth RatePoor
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate24.4418.9322.9712.58-12.04
Operating Profit Growth Rate89.6652.7332.146.31-65.25
Earnings Per Share (EPS) Growth-98.32-2464.5860.098.15-79.39
Asset Growth Rate-10.1910.2626.868.6213.21
Net Income Growth Rate-98.29-24001008.7-79
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

The financial ratios present a mixed view. Cash earnings per share is a strength, but adjusted earnings per share, book value per share, and dividend per share are low. The weighted average calculation reflects these mixed results. The company should focus on improving its earnings and book value to enhance its financial position. The company's capital expenditures are low which is not good for long-term.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)-0.731.4618.0419.615.49
Cash Earnings Per Share (Cash EPS)20.7324.6324.5126.4710.98
Book Value Per Share158.05168.05229.41248.63252.55
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)1462665150375
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 4.40

The company's profitability is mixed. Return on capital employed and return on assets are strengths, but gross profit margin, return on equity, operating margin, and net margin are low. The weighted average calculation highlights the need to improve overall profitability. The company should focus on increasing its margins and returns to achieve better financial performance.

PoorGross Profit MarginPoor
ExcellentReturn on Capital Employed (ROCE)Excellent
PoorReturn on Equity (ROE)Poor
AverageReturn on Assets (ROA)Average
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin-5.714.359.5290.74
Return on Capital Employed (ROCE)-25983
Return on Equity (ROE)-0.316.687.867.891.63
Return on Assets (ROA)4.956.867.146.992.15
Operating Margin9.8212.6113.5512.85.06
Net Margin-0.366.9111.2310.852.59
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The efficiency ratios show a mixed picture. While days sales in inventory and receivable days are managed well, the turnover ratios for fixed assets, inventory, receivables, and capital are low. The weighted average calculation highlights the need to improve asset utilization. The company should focus on optimizing its operations to enhance efficiency and improve overall asset turnover. This could lead to better profitability and return on investment.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio0.961.161.321.461.17
Inventory Turnover Ratio3.633.163.012.842.77
Receivables Turnover Ratio3.653.453.994.213.21
Days Sales in Inventory Ratio100.55115.51121.26128.52131.77
Receivable Days100105.891.4886.7113.71
Capital Turnover Ratio0.650.790.630.660.5
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company's coverage ratios are supported by a strong interest coverage ratio. The weighted average calculation shows a reasonable ability to cover interest expenses, but no ability to cover equity dividend payments. This suggests that while the company can manage its debt obligations, it is not in a position to provide returns to equity holders through dividends.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio1.062.456.417.42.62
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency is strong, with a very strong equity position. The weighted average calculation, gives a positive view of the company's long-term financial stability. This suggests that the company has a low level of debt relative to its assets. The company's equity position provides a solid foundation for future growth and stability.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.240.180.090.090.21
Debt to Equity Ratio0.320.220.10.10.27
Equity Ratio0.760.820.910.910.79
Debt To Asset Ratio0.190.120.080.080.17
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, indicating potential difficulties in meeting short-term obligations. The weighted average calculation, which emphasizes recent performance, reveals consistently low ratios. This might be because the company is unable to efficiently convert its current assets into cash. This situation needs immediate attention to avoid any financial distress.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.851.453.263.22.84
Quick Ratio1.170.862.252.071.96
Cash Ratio0.030.081.020.620.29
Operating Cash Flow Ratio0.360.050.480.070.35
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 21 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
2Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
3Aarti Pharmalabs Ltd7.4635.90Neutral369.0019.44175.00
4Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
5Akums Drugs & Pharmaceuticals Ltd7.2837.30Overvalued522.007.09256.00
6Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
7RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
8Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
9Alembic Ltd7.067.28Undervalued90.004.85317.00
10SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
11Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
12Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
13IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
14Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
15Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
16Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
17Sequent Scientific Ltd4.61293.05Overvalued162.000.6332.00
18Sun Pharma Advanced Research Company Ltd4.354.97Neutral1599.0047.831553.00
19Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
20Zota Health Care Ltd3.97-61.25Neutral19.008.06-74.00
Management Assessment Summary
OrangeBalanced Management

Orchid Pharma Ltd's management effectiveness shows potential amidst certain challenges. Sales and profit growth have improved, but a significant decrease in promoter holding and inefficient working capital management are concerning. The company's financial health has been bolstered by substantial debt reduction, but inconsistent profitability remains a point of concern. Overall, the management demonstrates a mixed performance, requiring strategic improvements in key areas.

Category Metric Value Assessment
PROS Sales Growth (3Y) 18% Revenue expansion is improving
Profit Growth (3Y) 249% Profit growth is improving
CONS Promoter Holding (Mar 2025) 69.84% Confidence and alignment with shareholders is weak
Cash Conversion Cycle (Mar 2025) 166 Days Working capital management is inefficient
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
GoodFinancial Health & PrudenceGood
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Orchid Pharma has a moderate risk profile. Debt has been reduced, but operational efficiency is a concern due to the high cash conversion cycle. Volatility in quarterly profit growth and a decrease in promoter holding raise concerns about stability. Financial health has improved, but working capital management and profitability challenges persist.

AverageForeign exchange or interest rate exposureAverage
GoodAccounting quality red flagsGood
01.

Foreign exchange or interest rate exposure

02.

Accounting quality red flags

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10991.48Bearish
  3. SMA 201009.91Bearish
  4. SMA 50955.34Bullish
  5. EMA 10988.18Bearish
  6. EMA 20991.27Bearish
  7. EMA 50959.72Bullish
  8. DEMA 10976.20Bearish
  9. DEMA 201000.01Bearish
  10. DEMA 501017.97Bearish
  11. TEMA 10966.40Bullish
  12. TEMA 20981.14Bearish
  13. TEMA 501021.59Bearish
  14. MACD3.35Bearish
  15. ADX36.40Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.27Neutral
  3. CCI-122.48Oversold
  4. ROC 9-4.57Bearish
  5. ROC 14-6.58Bearish
  6. ROC 255.85Bullish
  7. Stoch K4.62Oversold
  8. Stoch D5.08Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1055.74Neutral
  3. BB Middle1009.90Neutral
  4. BB Lower964.07Neutral
  5. ATR20.64High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI8.17Oversold

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101004.36Bearish
  3. SMA 20992.17Bearish
  4. SMA 50911.06Bullish
  5. EMA 10990.62Bearish
  6. EMA 20978.27Bearish
  7. EMA 50920.14Bullish
  8. DEMA 10990.03Bearish
  9. DEMA 201014.29Bearish
  10. DEMA 501006.03Bearish
  11. TEMA 10971.83Bearish
  12. TEMA 201004.80Bearish
  13. TEMA 501023.55Bearish
  14. MACD23.63Bearish
  15. ADX52.67Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI51.69Neutral
  3. CCI-37.70Neutral
  4. ROC 9-6.02Bearish
  5. ROC 147.20Bullish
  6. ROC 2514.55Bullish
  7. Stoch K38.81Neutral
  8. Stoch D42.25Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1066.22Neutral
  3. BB Middle992.17Neutral
  4. BB Lower918.12Neutral
  5. ATR29.10Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI78.55Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10991.04Bearish
  3. SMA 20927.62Bullish
  4. SMA 50826.63Bullish
  5. EMA 10977.21Bearish
  6. EMA 20937.47Bullish
  7. EMA 50846.46Bullish
  8. DEMA 101011.07Bearish
  9. DEMA 201009.70Bearish
  10. DEMA 50968.88Bullish
  11. TEMA 101002.12Bearish
  12. TEMA 201020.78Bearish
  13. TEMA 50N/AN/A
  14. MACD53.60Bearish
  15. ADX51.07Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI59.59Neutral
  3. CCI49.19Neutral
  4. ROC 91.40Bullish
  5. ROC 1414.12Bullish
  6. ROC 2516.47Bullish
  7. Stoch K59.19Neutral
  8. Stoch D66.00Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1072.02Neutral
  3. BB Middle927.62Neutral
  4. BB Lower783.22Neutral
  5. ATR42.92Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI83.87Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10934.95Bullish
  3. SMA 20858.37Bullish
  4. SMA 50719.59Bullish
  5. SMA 100662.85Bullish
  6. SMA 200715.80Bullish
  7. EMA 10945.32Bullish
  8. EMA 20878.46Bullish
  9. EMA 50769.21Bullish
  10. EMA 100721.48Bullish
  11. EMA 200738.84Bullish
  12. DEMA 101015.73Bearish
  13. DEMA 20986.30Bearish
  14. DEMA 50871.92Bullish
  15. DEMA 100748.52Bullish
  16. DEMA 200660.31Bullish
  17. TEMA 101024.97Bearish
  18. TEMA 201017.96Bearish
  19. TEMA 50961.00Bullish
  20. TEMA 100827.71Bullish
  21. TEMA 200687.72Bullish
  22. MACD82.77Bullish
  23. ADX66.90Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI71.53Overbought
  3. CCI110.78Overbought
  4. ROC 1425.99Bullish
  5. ROC 2536.12Bullish
  6. Stoch K74.17Neutral
  7. Stoch D81.80Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1060.11Neutral
  3. BB Middle858.37Neutral
  4. BB Lower656.63Neutral
  5. ATR52.32Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI88.04Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20644.56Bullish
  3. SMA 50714.76Bullish
  4. EMA 20700.19Bullish
  5. EMA 50743.16Bullish
  6. DEMA 20717.12Bullish
  7. DEMA 50638.08Bullish
  8. TEMA 20781.02Bullish
  9. TEMA 50620.21Bullish
  10. MACD24.28Bullish
  11. ADX29.99Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI62.40Neutral
  3. CCI166.13Overbought
  4. ROC 1480.34Bullish
  5. ROC 2516.52Bullish
  6. Stoch K93.91Overbought
  7. Stoch D90.93Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper870.42Overbought
  3. BB Middle644.56Neutral
  4. BB Lower418.70Neutral
  5. ATR72.33High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.82Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6663.08Bullish
  3. SMA 12702.40Bullish
  4. SMA 24974.02Bearish
  5. EMA 6685.40Bullish
  6. EMA 12736.66Bullish
  7. EMA 24805.66Bearish
  8. DEMA 6665.56Bullish
  9. DEMA 12631.10Bullish
  10. DEMA 24766.63Bullish
  11. TEMA 6705.43Bullish
  12. TEMA 12605.46Bullish
  13. TEMA 24N/AN/A
  14. MACD43.17Bearish
  15. ADX20.11Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI51.98Neutral
  3. CCI-0.75Neutral
  4. ROC 25-26.53Bearish
  5. ROC 50177.88Bullish
  6. Stoch K11.87Oversold
  7. Stoch D39.55Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1627.37Neutral
  3. BB Middle897.50Neutral
  4. BB Lower167.63Neutral
  5. ATR195.72High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.34Neutral